The Real Anthony Fauci Book › Citations Chapter 12 This is a listing of all citations in this chapter. 59.1 US Department of Justice, “Amerithrax Investigative Summary,” Feb. 19, 2010. 59.2 National Research Council, 2011, Review of the Scientific Approaches Used During the FBI’s Investigation of the 2001 Anthrax Letters, Washington, DC: The National Academies Press. 60 Whitney Webb and Raul Diego, “Head of the Hydra—The Rise of Robert Kadlec,” The Last American Vagabond (May 14, 2020). 61 Jerry Markon, “Justice Dept. Takes on Itself in Anthrax Attacks,” Washington Post (Jan. 27, 2012). 62 Ian Gurney, “Bin Laden Profits from U.S. Anthrax Vaccine Manufacture?” What Really Happened (2002). 63 Whitney Webb and Raul Diego, “Head of the Hydra—The Rise of Robert Kadlec,” The Last American Vagabond (May 14, 2020). 64 Jeffrey Lean and Jonathan Owen, “Donald Rumsfeld makes $5m killing on bird flu drug,” Independent (Mar. 12, 2016). 65 Nelson D. Schwartz, “Rumsfield’s Growing Stake in Tamiflu,” CNN Money (Oct. 31, 2005). 66 Nelson D. Schwartz, “Rumsfield’s Growing Stake in Tamiflu,” CNN Money (Oct. 31, 2005). 67 Jon Cohen and Eliot Marshall, “Vaccines for Biodefense: A System in Distress,” Science (Oct. 19, 2001), 498–501. 68 David Franz, “The Dual Use Dilemma: Crying out for Leadership,” Saint Louis University Journal of Health Law and Policy 7 no. 5 (2013), 6. 69 Jon Cohen and Eliot Marshall, “Vaccines for Biodefense: A System in Distress,” Science (Oct. 19, 2001), 498–501. 70 Paul D. Thacker, “A Continued Candid Conversation with Richard Ebright on the History of U.S. Research Funding for Biological Agents in America and Abroad That Lack Critical Safety Overview,” Disinformation Chronicle (Aug. 7, 2021). 71 Anthony S. Fauci, “The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research,” 6 no. 8 Nature (Aug. 2005): 745. 71.1 “Emergency Preparedness and Response—Bioterrorism Agents/Diseases,” CDC, Apr. 4, 2018. 72 Shankar Vedantam, “Lingering Worries Over Vaccine,” Washington Post (Dec. 20, 2001). 73 ABC This Week (Oct. 28, 2001). 74 Shankar Vedantam, “Lingering Worries Over Vaccine,” Washington Post (Dec. 20, 2001). 75 “The Anthrax Vaccine: Officials are taking another look at the controversial anthrax vaccine, Betty Ann Bowser reports,” PBS (Dec. 4, 2001). 76 “The Anthrax Vaccine: Officials are taking another look at the controversial anthrax vaccine, Betty Ann Bowser reports,” PBS (Dec. 4, 2001). 77 John Dudley Miller, “Postal Anthrax Aftermath: Has Bio-Defense Spending Made Us Safer?” Scientific American (Nov. 1, 2008). 78 Frequently Asked Questions About SARS, CDC (Mar. 3, 2005). 79 Fiona Fleck, “SARS outbreak over, but concerns for lab safety remain,” Bulletin of the WHO 82 (6) (Jun. 2004), 470. 80 “Anthony S. Fauci Reflects on the 2001 Anthrax Attacks,” RWJF (Oct. 3, 2011). 81 David Franz, “The Dual Use Dilemma: Crying out for Leadership,” Saint Louis University Journal of Health Law and Policy Vol. 7:5 (2013), 6. 82 Judith Miller, Stephen Engelberg, and William J. Broad, “U.S. Germ Warfare Research Pushes Treaty Limits,” The New York Times (Sept. 4, 2001). 83 Hsinchun Chen, et al. “Argus,” Infectious Disease Informatics: Syndromic Surveillance for Public Health and BioDefense 21 (Jul. 14, 2009): 177–181, doi:10.1007/978-1-4419-1278-7_13. 84 “Local Challenges of Global Proportions: Evaluating Roles, Preparedness for, and Surveillance of Pandemic Influenza,” Committee on Homeland Security and Governmental Affairs, US Senate 110th Congress (Sept. 28, 2007). 85 Raul Diego, “DARPA’s Man in Wuhan,” Unlimited Hangout (Jul. 31, 2020). 86 Raul Diego, “DARPA’s Man in Wuhan,” Unlimited Hangout (Jul. 31, 2020). Page 3 of 11«12345...10...»Last »